Mrs. Patricia Mariann Carroll-fackler, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 177 West Main St, Shelby, OH 44875 Phone: 419-342-3473 |
Mrs. Christine Lynn Grassel, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 177 W Main St, Shelby, OH 44875 Phone: 419-342-3473 |
Stroup Chiropractic Clinic, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 110 W Smiley Ave, Shelby, OH 44875 Phone: 419-342-6000 Fax: 419-342-6002 |
Dr. Daniel L Stroup, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 110 W Smiley Ave, Shelby, OH 44875 Phone: 419-342-6000 Fax: 419-342-6002 |
Mr. Mark William Hogue, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 100 North Gamble Street, Shelby, OH 44875 Phone: 419-342-2931 Fax: 419-347-7096 |
Dr. Thomas Eugene Rinehart, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 152 Mansfield Ave, Shelby, OH 44875 Phone: 419-347-2786 Fax: 419-347-2786 |
Dr. Gregory Scott Rinehart, D.C. Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 152 Mansfield Ave, Shelby, OH 44875 Phone: 419-347-2786 Fax: 419-347-2786 |
Fackler Family Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 177 W Main St, Shelby, OH 44875 Phone: 419-342-3473 |
News Archive
The Ohio State University Wexner Medical Center is one of six locations nationally - and the only one in the Midwest - studying the safety and effectiveness of a promising new technology using MR-guided focused ultrasound to treat patients suffering from essential tremor as part of a multi-center FDA trial.
By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
New research published in Cogent Medicine has found that deaths related to carbon monoxide (CO) poisoning have risen sharply in recent years in mainland China.
› Verified 6 days ago